European pharma stocks fall after Trump slaps 100% tariffs on medicine imports

European pharma stocks fall after Trump slaps 100% tariffs on medicine imports


Stocks listed in Europe were broadly higher on Friday, as investors assessed the latest trade policy announcements out of the White House.

The pan-European Stoxx 600 index was up by 0.2% by around 10:00 a.m. London time (5 a.m. ET), with most sectors in positive territory.

The Stoxx Europe 600 Healthcare index saw rocky trade in the morning, oscillating above and below the flatline. It was last seen trading 0.2% lower.

Overnight, President Donald Trump announced that pharmaceutical imports to the U.S. would be hit with 100% tariffs from Oct. 1. Companies who built manufacturing facilities in America would be exempt, Trump said, but only once they started breaking ground on the construction of U.S. plants.

Previously, Trump had threatened to impose tariffs of up to 200% on pharma imports.

Denmark’s Zealand Pharma was last seen down 2.5%, while Novo Nordisk and Finland’s Orion were also trading more than 2% lower on Friday morning.

However, in a note circulated in the wake of Trump’s announcements, JP Morgan strategists downplayed the impact the new tariffs would have on the pharmaceutical sector.

The “potential 100% tariff should largely be avoidable with us based manufacturing buildout,” they said. “And while there remain a number of unknowns on tonight’s announcement … we continue to see a very manageable overall impact from tariffs to our large cap coverage.”

Trump also announced on his Truth Social platform on Thursday night that heavy trucks would be slapped with 25% tariffs from next month.

The European Union’s own trade policies are also in focus, after German newspaper Handelsblatt reported that the bloc was planning to impose tariffs of up to 50% on Chinese steel in the coming weeks.

On Thursday, European stocks closed lower following the Trump administration’s launch of a national security probe into medical device imports, which could pave the way for further tariffs.

Overnight in Asia, pharma stocks notched losses as investors reacted to the looming U.S. tariffs on the sector.

In terms of economic data, Friday will see the release of Spain’s latest inflation print, U.K. mortgage lending figures, and a report on European economic sentiment.



Source

Tech stocks suffer worst week in nearly a year, driven down by war worries, Meta legal woes
World

Tech stocks suffer worst week in nearly a year, driven down by war worries, Meta legal woes

Meta Platforms Chief Executive Mark Zuckerberg (C) arrives for a meeting U.S. Sen. Majority Leader John Thune (R-SD) on Capitol Hill on March 26, 2026 in Washington, DC. Andrew Harnik | Getty Images A bad week for stocks was particularly rough for tech investors, as the Nasdaq suffered its worst weekly drop since April 2025. […]

Read More
China’s BYD sees first profit drop since 2021, even as the Tesla-rival takes global EV crown
World

China’s BYD sees first profit drop since 2021, even as the Tesla-rival takes global EV crown

BYD new energy vehicles awaiting shipment for export in Yantai Port, Shandong, China on March 26, 2026. CFOTO | Future Publishing | Getty Images Chinese automaker BYD said Friday its annual sales rose to a record $116 billion, outpacing Tesla’s, but its profit fell for the first time since 2021 under pressure from cutthroat competition. BYD, the largest […]

Read More
1.4 million filers face tax refund delays amid IRS paper check phaseout
World

1.4 million filers face tax refund delays amid IRS paper check phaseout

Tunyada Kongkapan | E+ | Getty Images A growing number of filers are facing tax refund delays amid a government-wide phaseout of paper checks.     House Ways and Means Committee Democrats this week sent another letter to Treasury Secretary Scott Bessent, with “additional concerns” about roughly 1.4 million IRS notices sent to filers about refund delays […]

Read More